The accuracy of colposcopic biopsy: Analyses from the placebo arm of the Gardasil clinical trials

International Journal of Cancer

Volumn 128, Issue 6, 2011, Pages 1354-1362

  Stoler, Mark H ^a   Vichnin, Michelle D ^b   Ferenczy, Alex ^c   Ferris, Daron G ^d   Perez, Gonzalo ^e   Paavonen, Jorma ^f   Joura, Elmar A ^g   Djursing, Henning ^h   Sigurdsson, Kristján ^i,j   Jefferson, Lucy ^k   Alvarez, Frances ^b   Sings, Heather L ^b   Lu, Shuang ^b   James, Margaret K ^b   Saah, Alfred ^b   Haupt, Richard M ^b  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c MCGILL UNIVERSITY   (Canada)

^d MEDICAL COLLEGE OF GEORGIA   (United States)

^e UNIVERSIDAD DEL ROSARIO   (Colombia)

^f HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^g UNIV KLIN FÜR FRAUENHEILKUNDE   (Austria)

^h FREDERIKSBERG HOSPITAL   (Denmark)

ⁱ National Cancer Detection Clinic   (Iceland)

^j UNIVERSITY OF ICELAND   (Iceland)

^k HOSPITAL NACIONAL ARZOBISPO LOAYZA   (Peru)

more..

Author keywords

biopsy; cervical cancer; colposcopy; HPV; papillomavirus; vaccine

Indexed keywords

PLACEBO; WART VIRUS VACCINE;

ADENOCARCINOMA IN SITU; ADOLESCENT; ADULT; ARTICLE; CANCER GRADING; CARCINOMA IN SITU; COLPOSCOPY; CORRELATION ANALYSIS; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PAPILLOMAVIRUS INFECTION; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU;

ADENOCARCINOMA; ADOLESCENT; ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; COLPOSCOPY; DNA, VIRAL; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PLACEBOS; PROGNOSIS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; YOUNG ADULT;

EID: 79551491522     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25470     Document Type: Article

References (36)

1. Cantor SB, Cardenas-Turanzas M, Cox DD, Atkinson EN, Nogueras-Gonzalez GM, Beck JR, Follen M, Benedet JL,. Accuracy of colposcopy in the diagnostic setting compared with the screening setting. Obstet Gynecol 2008; 111: 7-14.
2. Kitchener HC, Castle PE, Cox JT,. Achievements and limitations of cervical cytology screening. Vaccine 2006; 24: 63-70.
3. Stoler MH,. Advances in cervical screening technology. Mod Pathol 2000; 13: 275-84.
4. Sigurdsson K, Sigvaldason H,. Effectiveness of cervical cancer screening in Iceland, 1964-2002: a study on trends in incidence and mortality and the effect of risk factors. Acta Obstet Gynecol Scand 2006; 85: 343-9. (Pubitemid 43879222)
5. Jeronimo J, Massad LS, Castle PE, Wacholder S, Schiffman M,. Interobserver agreement in the evaluation of digitized cervical images. Obstet Gynecol 2007; 110: 833-40.
6. Apgar B, Brotzman G, Spitzer M, Ignatavicius DD,. In:, Apgar B, Brotzman G, Spitzer M, Ignatavicius DD, eds. Colposcopy, principles and practice: an integrated textbook and atlas, 1st edn. Philadelphia, PA: WB Saunders Company, 2002. 463-71.
7. Ferris DG, Cox JT, O'Connor DM, Wright VC, Foerster J,. Modern colposcopy, textbook and atlas, 2nd edn. Dubuque, Iowa: Kendall/Hunt Publishing, 2004.
8. Mitchell MF, Schottenfeld D, Tortolero-Luna G, Cantor SB, Richards-Kortum R,. Colposcopy for the diagnosis of squamous intraepithelial lesions: a meta-analysis. Obstet Gynecol 1998; 91: 626-31. (Pubitemid 28153058)
9. ASCUS-LSIL Triage Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. Am J Obstet Gynecol 2003; 188: 1393-400.
10. Gage JC, Hanson VW, Abbey K, Dippery S, Gardner S, Kubota J, Schiffman M, Solomon D, Jeronimo J,; ASCUS-LSIL Triage Study (ALTS) Group. Number of cervical biopsies and sensitivity of colposcopy. Obstet Gynecol 2006; 108: 264-72.
11. Ferris DG, Litaker MS,. Prediction of cervical histologic results using an abbreviated Reid colposcopic index during ALTS. Am J Obstet Gynecol 2006; 194: 704-10.
12. Bekkers RL, Nieuwnhof HP, Neesham DE, Hendriks JH, Tan J, Quinn MA,. Does experience in colposcopy improve identification of high grade abnormalities? Eur J Obstet Gynecol Reprod Biol 2008; 141: 75-8.
13. Baum ME, Rader JS, Gibb RK, McAlister RP, Powell MA, Mutch DG, Gao F, Wright JD,. Colposcopic accuracy of obstetrics and gynecology residents. Gynecol Oncol 2006; 103: 966-70.
14. Massad LS, Jeronimo J, Schiffman M,. Interobserver agreement in the assessment of components of colposcopic grading. Obstet Gynecol 2008; 111: 1279-84.
15. Pretorius RG, Zhang WH, Belinson JL, Huang MN, Wu LY, Zhang X, Quiao YL,. Colposcopically directed biopsy, random cervical biopsy, and endocervical curettage in the diagnosis of cervical intraepithelial neoplasia II or worse. Am J Obstet Gynecol 2004; 191: 430-4.
16. Solomon D, Stoler M, Jeronimo J, Khan M, Castle P, Schiffman M,. Diagnostic utility of endocervical curettage in women undergoing colposcopy for equivocal or low-grade cytologic abnormalities. Obstet Gynecol 2007; 110: 288-95.
17. Garland SM, Hernandez-Avila M, Wheeler CM, Perez G, Harper DM, Leodolter S, Tang GWK, Ferris DG, Steben M, Bryan JT, Taddeo FJ, Railkar R, et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med 2007; 356: 1928-43. (Pubitemid 46740303)
18. The FUTURE II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med 2007; 356: 1915-27.
19. Munoz N, Manalastas R, Pitisuttihum P, Tresukosol D, Monsonego J, Ault K, Clavel C, Luna J, Myers E, Hood S, Bautista O, Bryan J, et al. Safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women between 24 and 45 years of age: a randomized, double-blind trial. Lancet 2009; 373: 1921-2.
20. Henry MR,. The Bethesda system 2001: an update of new terminology for gynecologic cytology. Clin Lab Med 2003; 23: 585-603.
21. Fleiss JL,. Statistical methods for rates and proportions, 2nd edn. New York, NY: Wiley, 1981.
22. Hochberg Y,. A sharper Bonferroni procedure for multiple tests of significance. Biometrika 1988; 75: 800-2.
23. Massad LS, Halperin CJ, Bitterman P,. Correlation between colposcopically directed biopsy and cervical loop excision. Gynecol Oncol 1996; 60: 400-3.
24. ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 2003; 188: 1383-92.
25. Castle PE, Stoler MH, Solomon D, Schiffman M,. The relationship of community biopsy-diagnosed cervical intraepithelial neoplasia grade 2 (CIN2) to the quality control pathology-reviewed diagnosis: an ALTS report. Am J Clin Pathol 2007; 127: 805-15.
26. Chan JK, Monk BJ, Brewer C, Keefe KA, Osann K, McMeekin S, Rose GS, Youssef M, Wilczynski SP, Meyskens FL, Berman ML,. HPV infection and number of lifetime sexual partners are strong predictors for 'natural' regression of CIN 2 and 3. Br J Cancer 2003; 89: 1062-6.
27. Ostor AG,. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol 1993; 12: 186-92.
28. Wentzensen N, Zuna RE, Sherman ME, Gold MA, Schiffman M, Dunn ST, Jeronimo J, Zhang R, Walker J, Wang SS,. Accuracy of cervical specimens obtained for biomarker studies in women with CIN3. Gynecol Oncol 2009; 115: 493-6.
29. Jeronimo J, Massad LS, Schiffman M,. Visual appearance of the uterine cervix: correlation with human papillomavirus detection and type. Am J Obstet Gynecol 2007; 197: 47-8.
30. Sideri M, Schettino F, Spinaci L, Spolti N, Crosignani P,. Operator variability in disease detection and grading by colposcopy in patients with mild dysplastic smears. Cancer 1995; 76: 1601-5.
31. Wright TJ, Massad L, Dunton C, Spitzer M, Wilkinson E, Solomon D,. 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. J Low Genit Tract Dis 2007; 11: 223-39. (Pubitemid 47530910)
32. Wright TJ, Massad L, Dunton C, Spitzer M, Wilkinson E, Solomon D,. 2006 consensus guidelines for the management of women with abnormal cervical screening tests. J Low Genit Tract Dis 2007; 11: 201-22. (Pubitemid 47530909)
33. Cai B, Ronnett BM, Stoler M, Ferenczy A, Kurman RJ, Sadow D, Alvarez F, Pearson J, Sings HL, Barr E, Liaw KL,. Longitudinal evaluation of interobserver and intraobserver agreement of cervical intraepithelial neoplasia diagnosis among an experienced panel of gynecologic pathologists. Am J Surg Pathol 2007; 31: 1854-60.
34. Malpica A, Matisic JP, Niekirk DV, Crum CP, Staerkel GA, Yamal JM, Guillaud MH, Cox DD, Atkinson EN, Adler-Storthz K, Poulin NM, Macaulay CA, et al. Kappa statistics to measure interrater and intrarater agreement for 1790 cervical biopsy specimens among twelve pathologists: qualitative histopathologic analysis and methodologic issues. Gynecol Oncol 2005; 99: S38-S52.
35. Franco EL, Cuzick J, Hildesheim A, de Sanjose S,. Issues in planning cervical cancer screening in the era of HPV vaccination. Vaccine 2006; 24: 171-7.
36. Chase DM, Kalouyan M, DiSaia PJ,. Colposcopy to evaluate abnormal cervical cytology in 2008. Am J Obstet Gynecol 2009; 200: 472-80.